Project Overview
Galaxy Pharma is a pharmaceutical company operating across Pakistan and the UAE, focused on bringing high-quality international pharmaceutical products to market. The mandate was to lead end-to-end go-to-market strategy for multiple new product launches — working in close collaboration with global partners including LG Chem (South Korea), Besins Healthcare, and Lo.LI Pharma International.
Each product launch began with deep market research to surface unmet clinical needs — identifying the therapeutic gaps that neither local nor competing international brands were addressing. This research informed every downstream decision: product positioning, target physician profiles, channel strategy, and messaging frameworks tailored to the regulatory and cultural realities of each market.
Cross-functional collaboration was central to the work. Coordinating between regional commercial teams in Pakistan and the UAE and global product and medical affairs teams across multiple time zones required clear communication, structured processes, and the ability to translate complex clinical data into compelling market narratives that resonated with local healthcare professionals.
The result was a series of successful product launches that added $10 million in revenue — expanding Galaxy Pharma's commercial footprint and establishing new therapeutic categories in both markets.
